Concepedia

Sandra Lazzaro

SL

Statistics

Publications

5

Citations

501

H-Index

5

Active since

2011

Affiliations

CureVac (Germany)(Current)

Sandra Lazzaro is an author at CureVac (Germany) specializing in immunology, vaccination, and immunization.

Publications per year

2011–2022

5

Publications

5

Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines

Johannes Lutz, Sandra Lazzaro, Mohamed Habbeddine et al. · npj Vaccines · 2017 · 260 citations · Full text

, , +17

The miR-155–PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation

Dong Lu, Rinako Nakagawa, Sandra Lazzaro et al. · The Journal of Experimental Medicine · 2014 · 91 citations · Full text

, , +17

<scp>CD</scp>8 T‐cell priming upon <scp>mRNA</scp> vaccination is restricted to bone‐marrow‐derived antigen‐presenting cells and may involve antigen transfer from myocytes

Sandra Lazzaro, Cinzia Giovani, Simona Mangiavacchi et al. · Immunology · 2015 · 84 citations · Full text

, , +17

The ISWI Chromatin Remodeler Organizes the hsrω ncRNA–Containing Omega Speckle Nuclear Compartments

Maria Cristina Onorati, Sandra Lazzaro, Moushami Mallik et al. · PLoS Genetics · 2011 · 46 citations · Full text

, , +17

Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study

Xavier Sáez‐Llorens, Claudio F. Lanata, Elaine Aranguren et al. · Vaccine X · 2022 · 20 citations · Full text

, , +17

1–5 of 5